Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of color...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/10/2229 |
id |
doaj-3f7283d9c06046f19b2f0823532ad05c |
---|---|
record_format |
Article |
spelling |
doaj-3f7283d9c06046f19b2f0823532ad05c2020-11-24T22:04:12ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-10-011810222910.3390/ijms18102229ijms18102229Immunogenomic Classification of Colorectal Cancer and Therapeutic ImplicationsJessica Roelands0Peter J. K. Kuppen1Louis Vermeulen2Cristina Maccalli3Julie Decock4Ena Wang5Francesco M. Marincola6Davide Bedognetti7Wouter Hendrickx8Tumor Biology, Immunology, and Therapy Section, Immunology, Inflammation, and Metabolism Department, Division of Translational Medicine, Sidra Medical and Research Center, PO Box 26999 Doha, QatarDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The NetherlandsAcademic Medical Center Amsterdam, Center for Experimental Molecular Medicine, 1105AZ Amsterdam, The NetherlandsTumor Biology, Immunology, and Therapy Section, Immunology, Inflammation, and Metabolism Department, Division of Translational Medicine, Sidra Medical and Research Center, PO Box 26999 Doha, QatarQatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, PO Box 5825 Doha, QatarOffice of the Chief Research Officer (CRO), Sidra Medical and Research Center, PO Box 26999 Doha, QatarOffice of the Chief Research Officer (CRO), Sidra Medical and Research Center, PO Box 26999 Doha, QatarTumor Biology, Immunology, and Therapy Section, Immunology, Inflammation, and Metabolism Department, Division of Translational Medicine, Sidra Medical and Research Center, PO Box 26999 Doha, QatarTumor Biology, Immunology, and Therapy Section, Immunology, Inflammation, and Metabolism Department, Division of Translational Medicine, Sidra Medical and Research Center, PO Box 26999 Doha, QatarThe immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, anti-tumor orientation are proposed per CMS.https://www.mdpi.com/1422-0067/18/10/2229colorectal cancertumor microenvironmentimmune contextureimmunologic constant of rejectionconsensus molecular subtypesimmunotherapycombination therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jessica Roelands Peter J. K. Kuppen Louis Vermeulen Cristina Maccalli Julie Decock Ena Wang Francesco M. Marincola Davide Bedognetti Wouter Hendrickx |
spellingShingle |
Jessica Roelands Peter J. K. Kuppen Louis Vermeulen Cristina Maccalli Julie Decock Ena Wang Francesco M. Marincola Davide Bedognetti Wouter Hendrickx Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications International Journal of Molecular Sciences colorectal cancer tumor microenvironment immune contexture immunologic constant of rejection consensus molecular subtypes immunotherapy combination therapy |
author_facet |
Jessica Roelands Peter J. K. Kuppen Louis Vermeulen Cristina Maccalli Julie Decock Ena Wang Francesco M. Marincola Davide Bedognetti Wouter Hendrickx |
author_sort |
Jessica Roelands |
title |
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications |
title_short |
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications |
title_full |
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications |
title_fullStr |
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications |
title_full_unstemmed |
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications |
title_sort |
immunogenomic classification of colorectal cancer and therapeutic implications |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2017-10-01 |
description |
The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, anti-tumor orientation are proposed per CMS. |
topic |
colorectal cancer tumor microenvironment immune contexture immunologic constant of rejection consensus molecular subtypes immunotherapy combination therapy |
url |
https://www.mdpi.com/1422-0067/18/10/2229 |
work_keys_str_mv |
AT jessicaroelands immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT peterjkkuppen immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT louisvermeulen immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT cristinamaccalli immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT juliedecock immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT enawang immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT francescommarincola immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT davidebedognetti immunogenomicclassificationofcolorectalcancerandtherapeuticimplications AT wouterhendrickx immunogenomicclassificationofcolorectalcancerandtherapeuticimplications |
_version_ |
1725829948231385088 |